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Objectives: Aim of this study was to describe the use of antithrombotic therapy in
Chinese patients with atrial ﬁbrillation (AF) and identify factors associated with
warfarin use at baseline and at 12-month follow-up.
Methods: Between November 2008 and October 2011, this prospective registry
enrolled patients presenting to an emergency department (ED) with AF at 20 sites in
China; 12-month follow-up was completed for all patients. Multivariate regression
models were used to determine predictors of warfarin use, respectively.
Results: Among 319 patients with valvular AF, 132 at baseline and 111 at follow-up
were on warfarin, while 43 (32.6%) and 64 (57.7%) have international normalized
ratio (INR) levels between 2.0 to 3.0, respectively. In patients with non-valvular AF
warfarin was most used in patients with CHADS2 scores¼1, and proportion of
patients met the target INR levels increased as rising of the CHADS2 score. Use of
aspirin also increased with risk score rising. Over half of low-risk patients received
antithrombotic drugs (60.2% and 55.3%, respectively). History of stroke/transient
ischemic attack (TIA) and prior diagnosis of AF were predictors for warfarin use at
baseline, as well as at follow-up, while there was a decreased likelihood of warfarin
use as increasing age, increasing heart rate (HR), and history of coronary artery
disease (CAD).
Conclusions: In China, antithrombotic therapy were overused in AF patients at low
risk of stroke and underused in high-risk patients. History of stroke/TIA, prior
diagnosis of AF, age, heart rate, and history of CAD were related with warfarin use.
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Different inﬂuences of Single and Dual-chamber Pacing on Brachial Blood
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Miao Shuai, Ye Lan, Yan Zhehui, Li Guangping
The second hospital of Tianjin Medical University
Objectives: To assess the different effects of cardiac pacing mode on brachial blood
pressure, central aortic pressure (CAP) and augmentation index.
Methods: 103 pacemaker-implanted patients were enrolled in this study in cohort.
The 103 patients were divided into three groups: single-chamber pacemaker group (41
cases), dual-chamber pacemaker group (42 cases). But the control group (20 cases)
enrolled pacemaker-implanted patients without pacing while examined. The brachial
systolic blood pressure (SBP1), brachial diastolic blood pressure (DBP1), pulse
pressure (PP), central aortic pressure (CAP), augmentation index (AI) were measured
in all enrolled subjects. And then DDD pacing mode of patients in dual-chamber
pacemaker group was programmed into VVI pacing mode and these parameters were
measured again.
Results: The values of SBP1, DBP1, PP, CAP and AI in control group were
138.622.43 mmHg, 74.3512.65 mmHg, 67.0523.17 mmHg, 138.7018.69
mmHg and 78.9513.31 respectively; Those in dual-chamber pacemaker group were
143.7919.39 mmHg, 73.2410.11 mmHg, 70.3317.81 mmHg, 149.6719.62
mmHg and 88.1910.29 respectively; those values in single-chamber pacemaker
group were 121.2319.84 mmHg, 65.6211.22 mmHg, 56.9218.12 mmHg,
124.3319.34 mmHg and 81.2612.28 respectively. The SBP1, DBP1 and PP in
dual-chamber pacing group were signiﬁcantly higher than single-chamber pacing
group (P<0.05). The CAP and AI in dual-chamber pacing group was signiﬁcantly
higher than the control group and single-chamber pacing group (P<0.05). The CAP in
control group were signiﬁcantly higher than VVI group (P<0.05).
Conclusions: Dual-chamber pacing could signiﬁcantly enhance patients’ brachial
blood pressure. Dual-chamber pacing may boost people’s CAP and AI, which could
be attributed to one of the adverse effects on cardiovascular events and long-term
prognosis in patient with right apex pacing.
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Automatic home monitoring in patients with implantable cardioverter
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Objectives: To evaluate the beneﬁt of Home monitoring (HM) system in patients with
implantable cardioverter deﬁbrillator (ICD) or cardiac resynchronization therapy
deﬁbrillator (CRT-D).
Methods: Twenty-three patients undergoing implantation of ICD or CRT-D with HM
in our hospital were enrolled from January 2011 to August 2013. Data of patients were
transmitted by Home monitoring system. Data automatically collected on a daily basis
and alerts by HM were analyzed. Early detection and intervention effect of Home
monitoring system included arrhythmias or heart failure to clinical events and system
related events.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CResults: The mean follow-up duration was 452.1262.2 days, a total of 1991 remote
transmissions were received. Among these transmissions, 1481 abnormal events were
reported and 96.4% of events were clinical-related, and 1.5% were system-related, no
transmissions by 2.1%. Most of the system-related events were abnormal sensing, and
one loose electrode placement of left ventricular was detected. Clinical events
included 84.7% arrhythmic events and 15.3% HF monitoring events. Alerts for HF
monitoring including heart rate at rest were increasing and CRT pacing percentage
was reduced. Through alerts of the HM, patients got physician advices by telephone in
65 times, parameters were optimized in 11 times, and treatment plan was adjusted in18
times, four patients were hospitalized again.
Conclusions: Home monitoring is necessary and safe method which could early
detect the abnormal events in the patients with ICD or CRT-D, This system is helpful
in making earlier clinical intervention, and optimizing follow-up management, it may
improve patients, quality of life and safety.
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Objectives: CHADS2 and CHA2DS2-VASc have been validated as predictors of
embolic risk, contributing to the optimization of antithrombotic prescribing practices
in heterogeneous atrial ﬁbrillation (AF) patients. However, independent validations
have reported conﬂicting results. This meta-analysis therefore aimed to compare the
diverse predictive values of these two methods for risk assessment in AF individuals
with and without anticoagulation therapy based on previous studies.
Methods: The data were systematically retrieved by searching the Cochrane Library,
PubMed and Embase databases reporting the diagnostic performance between
CHADS2 and CHA2DS2-VASc. In addition, we reviewed references, major textbooks,
and review articles. Pooled risk ratios were estimated by using a random-effects
model. Deﬁned endpoints were then compared between scores<2 and2, considering
the presence or absence of anticoagulation therapy.
Results: Twelve cohort studies were identiﬁed in the meta-analysis. With regard to the
occurrence of outcomes individually, patients with CHA2DS2-VASc scores2
showed a greater risk for stroke (RR 5.31, CI 3.69-7.62; P<0.00001) and thrombo-
embolism (RR 5.94, CI 5.48-6.43; P<0.00001) (pdiff¼0.55), regardless of the
presence or absence of anticoagulation therapy (RR 5.43, CI 4.92-6.00; P<0.00001
and RR 5.92, CI 5.26-6.67; P<0.00001, respectively) (pdiff¼0.57). A chi-squared test
to evaluate trends also conﬁrmed an increased risk of events in patients receiving
anticoagulants (both ptrend<0.001).
Conclusions: Our results showed better diagnostic performance for CHA2DS2-VASc
over CHADS2 for the distribution of greater numbers of patients and a greater inci-
dence of endpoints events into the high-risk stratiﬁcation, as well as the identiﬁcation
of patients with atrial ﬁbrillation who are at substantial risk of endpoint events with or
without optimal anticoagulant therapy.
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Objectives: By trying implanting a ventricular electrode through the coronary sinus
(CS) approach to achieve the conventional cardiac pacing, this study was designed to
overcome the potential risk of the traditional right ventricular endocardial pacing
through the tricuspid valve approach.
Methods: (1) 61 patients in line with ordinary cardiac pacing were continually
enrolled. All cases were randomly divided into the research group of CS ventricular
pacing and the traditional right ventricular pacing group. (2) For the research group,
ﬁrstly patients underwent a routine perfusion imaging through the CS approach or
accepted an insertion of a mapping electrode or conventional right ventricular elec-
trode to search for the CS port, then a dedicated left ventricular electrode through
a pushing sheath or a conventional right ventricular electrode was planted into a
corresponding targeted vein. For the traditional right ventricular pacing group, a
conventional right ventricular electrode was planted through the tricuspid valve
approach. (3) Indexes such as the X-ray exposure time of ventricular electrode
implantation, the success rate, the operation complications, the pacing parameters
were collected. (4) The SPSS 17.0 statistical software package was used for data
processing, and there was a signiﬁcant difference if P<0.05.
Results: (1) The success rate of the study group lower than the traditional right
ventricular pacing group (65.52% vs 100%, P¼0.001). In the study group the success
rate of CRT-dedicated left ventricular electrodes and delivery sheathes was higher
than that of conventional right ventricular electrodes (80.95% vs 25%, P¼0.009). (2)
There was no signiﬁcant difference of the severe pacing- related complications rate
(10.34% vs 0%, P¼0.203) between the two groups and the traditional group, and all
61 patients survived. (3) The X-ray exposure time of the study group was longer
(3.852.21 min vs 7.435.56 min, P¼0.01). (4) Tests during operation showed thatardiovascular Disease Clinical Research C157
threshold of the study group was slightly higher than that of the traditional right
ventricular pacing group (1.431.05 V vs 0.660.35 V, P¼0.009). There was no
signiﬁcant difference of sensitivity (10.774.96 mV vs 9.662.93 mV, P¼0.367).
Impedance of the study group was slightly higher than that of the traditional right
ventricular group (884.35476.52 U vs 615.48214.89 U, P¼0.010).
Conclusions: (1) Among patients with conventional cardiac pacing, the replacement
of the classical right ventricular endocardial pacing through the tricuspid valve
approach with CS ventricular pacing is feasible, simple, and repeatable, and it is
worthy of further explorations. (2) The success rate of CS ventricular pacing with
conventional right ventricular electrodes implanted is rather low, while that with CRT-
dedicated electrodes implanted signiﬁcantly improves. (3) Complications such as
coronary sinus dissection, pericardial effusion, diaphragmatic stimulation and so
on may emerge during and after the operation of CS ventricular pacing, but that rate is
no higher than the traditional right ventricular pacing, and the pacing parameters are
no worse than the traditional right ventricular pacing. (4) CS ventricular pacing can
obtain more central ventricular activations’ QRS wave forms, make the pacing therapy
more physiological. (5) For patients with the contradiction of pacing through the
tricuspid valve approach, failing to implement CRT, and with complete left bundle
branch block, CS ventricular pacing can be a replacement of the traditional right
ventricular pacing.
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Objectives: We investigated the impact of clinical characteristics of premature
ventricular contraction (the PVC burden, the electrocardiography characteristics of
PVC, the site of origin of PVC, the duration of symptoms) on the Left ventricular
ejection fraction in patients without underlying structural heat disease, so that we can
make a suitable treatment for these PVC patients to prevent them from PVC-induced
cardiomyopathy.
Methods: We retrospectively studied 103 consecutive patients (mean age 3718
years, 69 female) with no other cause of cardiomyopathy who had accepted ablation of
PVCs in the 2nd Hospital of Jilin University from January, 2010 to October, 2013. We
analyzed the association of a reduced LVEF, deﬁned by LVEF <50% on echocar-
diography, with features of PVCs obtained from electrocardiography, 24- or 48-hour
Holter monitor and electrophysiology study.
Results: Patients with reduced LVEF (n¼35) as compared to normal LVEF (n¼68)
had an increased burden of PVCs (30.313.6% vs 17.713.0%, P¼0.007), higher
prevalence of nonsustained ventricular tachycardia (VT) [28 (80%) vs 27 (40%),
P¼0.045], longer QRS duration (155.322.5 vs 146.621.8 ms, P¼0.03) and longer
duration of symptom (4.91.7 yr vs 2.00.3 yr, P<0.01).There was no signiﬁcant
difference in age, sex, PVC coupling interval. Patients with fascicular PVCs (n¼7)
had higher mean LVEF compared to others (69.24.0% vs 57.010.0%, P¼0.0004).
There was no association of LVEF with the origin of PVC.
Conclusions: In addition to the PVC burden, other characteristics like a longer QRS
duration, presence of non-sustained VT and duration of symptoms might be associated
with cardiomyopathy.
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Impact of left atrial epicardial adiposity on recurrence of atrial ﬁbrillation after
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Objectives: To investigate the impact of left atrial epicardial adiposity on recurrence
of atrial ﬁbrillation (AF) after catheter ablation.
Methods: From 2009 to 2010, consecutive patients with AF who underwent
circumferential pulmonary vein ablation guided by 3-D mapping system were enrolled
in the retrospective study. Left atrial (LA) epicardial fat pad thickness was measured in
consecutive cardiac CT angiograms performed for AF. Patients were grouped by AF
burden: paroxysmal (n¼100), or persistent (n¼49) AF. The short-axis view was
reconstructed as a plane perpendicular to the long axis of these 2 views at the level of
the mid LA. In this short-axis view, the periatrial epicardial fat thickness was
measured (in cm) as the shortest distance between the mid left atrium (LA) wall and 3
anatomic landmarks: esophagus (LA-ESO), main pulmonary artery (LA-PA), and
descending thoracic aorta (LA-TA) In a short-axis view at the mid LA, periatrial
epicardial fat thickness was measured at the esophagus (LA-ESO), main pulmonary
artery, and thoracic aorta. The recurrence was deﬁned as atrial tachyarrhythmia lasting
more than 30 seconds beyond one month washout period.
Results: In this study population, 100 had paroxysmal AF, and 49 had persistent AF,
49 patients were female. The association between AF burden by grade (paroxysmal 1,
persistent 2). Differences in gender, age, LVEF, and comorbid factors were not
statistically signiﬁcant. Periatrial LA-ESO fat thickness was assessed by ordinal
logistic regression. Univariately, LA-ESO, LA-TA, LA-PA, and LAD were signiﬁcant
predictor of AF burden. After adjusting for age, BMI, LA-TA, LA-PA and LAD,
the association remained signiﬁcant (odds ratio, 0.407; 95% CI 0.246-0.673;
P¼0.00046).There was no loss to follow-up after 12 months. Of 149 patients, 98
(65.8%) remained free of recurrence after a single ablation procedure. The recurrence
patients had a signiﬁcantly thicker LA-ESO fat pad than the normal patients afterC158 JACC Vol 64/16/Suppl C j October 16–1ablation. By logistic regression modeling, after adjusting for AF burden, LAD,
age, and comorbid factors, LA-ESO fat depots were individually predictive of the
recurrence of AF (P¼0.002, OR¼0.444, 95% CI 0.268-0.734).
Conclusions: Left atrial epicardial adiposity is associated with the burden of AF, and
poorer outcomes after AF ablation. LA-ESO fat depots were individually predictive of
the recurrence of AF.
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Could the antegrade conduction of accessory pathway shorten PJ interval
in pre-excitation syndrome?
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Objectives: The pre-excitation syndrome could not prolong PJ interval. So, the dif-
ferential diagnosis between pre-excitation syndrome and bundle branch block (BBB)
could be made based on the prolonged PJ interval. Could the antegrade conduction of
accessory pathway (AP) shorten the PJ interval? In order to explore the effects of pre-
excitation on PJ interval, we studied patients with a single anterogradely conducting
AP who underwent successful ablation, compared the ECG pre and post ablation.
Furthermore, we further analyzed the mechanism and clinical signiﬁcance of pro-
longed PJ interval in pre-excitation syndrome.
Methods: In the study, 162 cases with a single anterogradely conducting AP who
underwent successful radiofrequency ablation were included. Patients were divided
into two groups according to the PJ interval post ablation. In normal group, 150 cases
were included (who were divided into 10 subgroups according to AP location). In
prolonged group, 12 cases were included (4 were ﬁrst degree atrioventricular block, 8
were BBB). (1) Normal group: comparison of 12-lead ECG during sinus rhythm pre
and post ablation was made. PR interval, QRS duration, and PJ interval were recorded
respectively. Furthermore, the delta wave duration, atrioventricular (AV) conduction
time via AV nodal pathway (normal pathway) pre ablation (sum of the PR interval and
delta wave duration equivalent), and the total time of ventricular depolarization via
normal pathway pre ablation (subtraction of the QRS interval and delta wave duration
equivalent) were measured. (2) Prolonged group: besides the indices which measured
in normal group, the region of heart block, AP location, and QRS morphology during
AV reentrant tachycardia (AVRT) pre ablation were analyzed.
Results: (1) Normal group: The PJ interval was not prolonged in all subgroups
compared with ECG post ablation. Furthermore, it was signiﬁcantly shortened in right
posterior (RP) AP (22618 VS 23619 ms; P<0.05) and right posteroseptal (RPS)
AP (22118 VS 23831 ms; P<0.05) compared with ECG post ablation. Accord-
ingly, the total ventricular activation time via normal pathway was shortened in RP AP
(7912 VS 879 ms; P<0.05) and RPS AP (7013 VS 869 ms; P<0.05). (2)
Prolonged group: the prolonged extent of PJ interval pre ablation was smaller
compared with ECG post ablation. In 4 cases with ﬁrst degree AVB, although the PJ
interval pre ablation was shortened compared with ECG post ablation, the PJ interval
was still longer than normal limits (0.26s). QRS was normal during AVRT. Out of
8 cases with BBB 6 had normal PJ interval pre ablation and 2 (AP was on the opposite
side as the ventricle having BBB) had prolonged PJ interval pre ablation. QRS was
BBB pattern during AVRT.
Conclusions: (1) Pre-excitation syndrome could not prolong the PJ interval, and may
even shorten it. When the AP was on the same side as the ventricle having BBB, the
PJ interval could be shortened to normal range. Normal PJ interval could not rule out
the presence of BBB, especially when the QRS is ipsilateral BBB pattern of AP during
AVRT. (2) The mechanism of shortened PJ interval is related to the reduction of total
ventricular depolarization time and AV conduction time (ﬁrst degree AVB) via normal
pathway. (3) A prolonged PJ interval could serve as a marker of preexistent AV or
interventricular conduction disturbance in pre-excitation. Measurement of the PJ
interval should be recommended in case with pre-excitation pre ablation of AP.
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Objectives: Type 2 long QT syndrome (LQT2) is caused by loss-of-function muta-
tions in KCNH2 gene (hERG) which encodes the pore-forming subunit of a rapidly
activating delayed rectiﬁer potassium channel. Therapy with b-blocker remains the
ﬁrst choice for LQT2, however, almost a quarter of patients still develop cardiac
events while taking adequate b-blocker therapy. This study aimed to investigate the
efﬁcacy and mechanism of a calcium channel blocker, verapamil, to improve clinical
manifestations in LQT2.
Methods: A 42-year-old woman who presented with marked QT prolongation and
torsades de pointes (TdP) underwent candidate gene screening. Therapeutic effects of
verapamil were evaluated by QT-interval measurement and ICD shock count. The
electrophysiological effect of verapamil was evaluated in a LQT2 model using rabbit
left ventricular myocardial wedge preparations.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
